Advanced search Help
Searching for terms: EXACT: "United States. Department of Health and Human Services" in: publisher
Clear all search criteria
Only 2/3! You are seeing results from the Public Collection, not the complete Full Collection. Sign in to search everything (see eligibility).
-
Vaccines National Strategic Plan: 2021-2025
From the Executive Summary: "Although significant progress against vaccine-preventable diseases has been made in the United States, there remain significant gaps in vaccination coverage that contribute to preventable morbidity and mortality each year. The Vaccines National Strategic Plan 2021-2025 (Vaccine Plan) provides a vision for the U.S. vaccine and immunization enterprise for the next 5 years as the nation seeks to eliminate vaccine-preventable diseases. The Vaccine Plan articulates a comprehensive strategy to promote vaccines and vaccination including research and development, vaccine safety monitoring, increase public knowledge and confidence in vaccines, increase access and use of recommended vaccines across the lifespan, and global cooperation. The Vaccine Plan builds on previous plans to guide vaccine policy to address vaccine confidence and disparities in vaccination coverage."
United States. Department of Health and Human Services
2021
-
Methods for Evaluating the Opioid Analgesic Risk Evaluation and Mitigation Strategy
From the Overview: "The Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS), required by the Food and Drug Administration (FDA) and implemented by the manufacturers of opioid analgesics intended for use in an outpatient setting, is one strategy among multiple national and state efforts to reduce the risk of abuse, misuse, addiction, overdose, and deaths caused by prescription opioid analgesics. The primary component of this risk evaluation and mitigation strategy (REMS) is a voluntary education program for prescribers, nurses, pharmacists, and other health care providers involved in the treatment or monitoring of patients with pain. A consortium of manufacturers, known as the REMS Program Companies (RPC), conducts annual assessments of the OA REMS and provides summaries of data that are used to determine whether the REMS is meeting its risk mitigation goals."
Center for Drug Evaluation and Research (U.S.); United States. Food and Drug Administration; United States. Department of Health and Human Services
2020-12-11
-
Healthcare Disinformation [presentation]
From the Introduction: "[1] Disinformation; also called 'active measures' when referring to its use by a state for national security and power projection purposes; [2] The difference between disinformation and misinformation is intent; [3] Not all false stories are organized campaigns pushed by a nation-state; [4] Often indistinguishable from conspiracies, and often piggy back on them; [5] Many countries, both powerful and established as well as smaller, engage in disinformation; [6] There are estimates of over 10,000 individual disinformation operations during the Cold War: [a] It's believed to be even more prevalent in the Internet Age; [7] Disinformation is very challenging to deal with because: [a] It can be difficult to identify, [b] It can be difficult to trace to its source, [c] It can be difficult to counteract; [8] Famous (recent) case: 2016 U.S. Presidential election; [9] This presentation will lean heavily towards Russia and its long history of leveraging disinformation, going back to at least the early days of the Soviet Union. Many countries utilize disinformation in the modern era."
United States. Department of Health and Human Services
2020-12-03
-
Caring for Women with Opioid Use Disorder: A Toolkit for Organization Leaders and Providers
From the Introduction: "Opioid use disorder (OUD) is a public health crisis affecting women, men, children, and society. Women with OUD have unique care needs and require a broad range of medical, behavioral health, and social services to meet these needs. Care coordination is important to manage the array of services that might be delivered to women in different settings. Without care coordination, women with OUD might struggle to access the services they need to get treatment and maintain recovery. This toolkit is a guide to help you and other health care and social service organization leaders and providers improve care coordination for women with OUD in HRSA [Health Resources and Services Administration]-supported programs. The information in this toolkit may also apply to other settings of care."
United States. Health Resources and Services Administration; United States. Department of Health and Human Services
2020-11
-
PPE Preservation Planning Toolkit
From the Document: "This toolkit is designed to aid organizations by maximizing the use of Personal Protective Equipment (PPE) by planning and implementing preservation strategies. It provides estimates of the value of implementing preservation actions to reduce (use of), to reuse, or to repurpose PPE, as described in the Coronavirus (COVID-19) [coronavirus disease 2019] Pandemic: Personal Protective Equipment Preservation Best Practices fact sheet, in conventional, contingency, or crisis capacity conditions (as defined in the Centers for Disease Control and Prevention's Optimizing Supply of PPE and Other Equipment during Shortages). Users enter data on their current or prospective PPE use practices. The toolkit assists users to understand preservation strategies their organizations can implement. It also provides estimates of the positive impacts of using those strategies in increasing the duration of PPE supplies."
United States. Federal Emergency Management Agency; United States. Department of Health and Human Services
2020-11
-
Answers to National Governors Association Questions on Vaccine Distribution and Planning
From the Document: "Since the spring, the Federal government has partnered with state, local, and tribal leaders to develop this whole-of-government plan and we will continue this collaboration. We recognize this process is iterative and welcome governors along with other state, local, and tribal officials' input and best practices. The answers provided below were developed by the U.S. Department of Health & Human Services (HHS) in partnership with our Federal partners including the Centers for Disease Control & Prevention (CDC) and the U.S. Department of Defense (DoD), among others."
United States. Department of Health and Human Services
2020-10-30?
-
Joint Cybersecurity Advisory: Ransomware Activity Targeting the Healthcare and Public Health Sector
From the Summary: "This joint cybersecurity advisory was coauthored by the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI), and the Department of Health and Human Services (HHS). This advisory describes the tactics, techniques, and procedures (TTPs) used by cybercriminals against targets in the Healthcare and Public Health Sector (HPH) to infect systems with ransomware, notably Ryuk and Conti, for financial gain. CISA, FBI, and HHS have credible information of an increased and imminent cybercrime threat to U.S. hospitals and healthcare providers. CISA, FBI, and HHS are sharing this information to provide warning to healthcare providers to ensure that they take timely and reasonable precautions to protect their networks from these threats."
United States. Department of Homeland Security. Cybersecurity and Infrastructure Security Agency; United States. Federal Bureau of Investigation; United States. Department of Health and Human Services
2020-10-28
-
ASPE TRACIE Technical Assistance Request: Protecting Community Hospitals and Providing Care During Civil Unrest [October 22, 2020]
From the Document: "The requestor asked for resources related to protecting community hospitals and providing care during civil unrest. [...] The ASPR TRACIE [Assistant Secretary for Preparedness and Response Technical Resources, Assistance Center, and Information Exchange] Team reviewed existing resources and conducted a search online for relevant materials. Although not directly related to this technical assistance (TA) request, we would like to provide the requestor with three ASPR TRACIE Topic Collections for reference: Mass Gatherings/Special Events, Responder Safety and Health, and Workplace Violence. The Hospital Lockdown Resources TA response document also provides useful resources related to hospital lockdown procedures for various types of events. Section I includes links to planning resources and lessons learned. Section II includes links to articles that examine the medical effects and treatment strategies for exposure to riot control tools (e.g., pepper spray, tear gas, and rubber bullets). Section III includes a list of symptoms and treatment strategies for individuals exposed to tear gas or pepper spray."
United States. Technical Resources, Assistance Center and Information Exchange; United States. Department of Health and Human Services. Office of the Assistant Secretary for Preparedness and Response
2020-10-22
-
Promoting Resilience & Recovery from the Effects of the COVID-19 Pandemic [presentation]
This resource "Promoting Resilience & Recovery from the Effects of the COVID-19 [coronavirus disease 2019] Pandemic" has a number of learning objectives. At the Individual level learning objectives include: "[1] Identify challenges and stressors in the COVID-19 environment; [2] Understand burnout/compassion fatigue/caution fatigue/moral injury/complex grief; and [3] Individual mitigation strategies for social workers." At the Organizational level learning objectives include: "[1] Identify organizational challenges in the COVID-19 environment; [2] Organizational mitigation strategies and tools; and [3] The role of communities in addressing impacts of COVID-19." Learning objectives associated with Ethical Considerations include: "[1] Identify ethical dilemmas within social work practice during disasters; [2] Ethical principles and NASW [National Association of Social Workers] Code of Ethics; and [3] Ethical mitigation strategies for practice."
United States. Department of Health and Human Services. Office of the Assistant Secretary for Preparedness and Response
Kaul, Rachel; Siviy, Kayla
2020-10-21?
-
National Action Plan for Combating Antibiotic-Resistant Bacteria
From the Executive Summary: "The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance. This Plan is based on the U.S. Government's 2014 National Strategy for CARB, and builds on the first National Action Plan released in 2015 by expanding evidence-based activities that have already been shown to reduce antibiotic resistance, such as optimizing the use of antibiotics in human and animal health settings. This Plan continues to prioritize infection prevention and control to slow the spread of resistant infections and reduce the need for antibiotic use. To ensure that patients receive the right antibiotic care, the Plan supports innovative approaches to developing and deploying diagnostic tests and treatment strategies. A One Health approach, which recognizes the relationships between the health of humans, animals, plants, and the environment, is integrated throughout the Plan, with an expanded effort to understand antibiotic resistance in the environment. The Plan also focuses on collecting and using data to better understand where resistance is occurring, support the development of new diagnostics and treatment options, and advance international coordination."
United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation
2020-10
-
Trump Administration Releases COVID-19 Vaccine Distribution Strategy
From the Webpage: "The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today released two documents outlining the Trump Administration's detailed strategy to deliver safe and effective COVID-19 [coronavirus disease 2019] vaccine doses to the American people as quickly and reliably as possible. The documents, developed by HHS in coordination with DoD and the Centers for Disease Control and Prevention (CDC), provide a strategic distribution overview along with an interim playbook for state, tribal, territorial, and local public health programs and their partners on how to plan and operationalize a vaccination response to COVID-19 within their respective jurisdictions."
United States. Department of Defense; United States. Department of Health and Human Services
2020-09-16
-
ASPR TRACIE Technical Assistance Request: COVID-19 and Seasonal Flu Vaccination Planning Resources
From the Document: "The requestor asked for information and resources on how healthcare facilities are planning for seasonal influenza vaccination, including the possibility of also providing COVID-19 [coronavirus disease 2019] vaccination during flu season. ASPR TRACIE [Office of the Assistant Secretary for Preparedness and Response Technical Resources, Assistance Center, and Information Exchange] reviewed existing resources on our Novel Coronavirus Resources page. We also reached out to several members of the ASPR TRACIE Subject Matter Expert (SME) Cadre for information on their policies and procedures and conducted an open source search for additional information. Section I includes feedback from the SME Cadre. Section II provides additional resources. Please refer to the Centers for Disease Control and Prevention's Coronavirus Disease 2019 webpage for the most up-to-date clinical guidance on COVID-19 outbreak management."
United States. Department of Health and Human Services. Office of the Assistant Secretary for Preparedness and Response; United States. Technical Resources, Assistance Center and Information Exchange
2020-09-03
-
Guidance for Licensed Pharmacists and Pharmacy Interns Regarding COVID-19 Vaccines and Immunity Under the PREP Act
From the Document: "The United States Department of Health and Human Services (HHS) is the lead agency for the federal government's response to the COVID-19 [coronavirus disease 2019] pandemic. A key component of that response will be access to a COVID-19 vaccine across the United States. Pharmacists, in partnership with other healthcare providers, are well-positioned to increase access to vaccinations--particularly in certain areas that have too few pediatricians and other primary-care providers, or that are otherwise medically underserved. [...] Nearly every State permits pharmacists to order and administer vaccines to both adults and children under certain circumstances. Therefore, as an Authority Having Jurisdiction under the Secretary's March 10, 2020 declaration under the Public Readiness and Emergency Preparedness Act (PREP Act), the Office of the Assistant Secretary for Health (OASH) issues this guidance. Subject to satisfaction of the requirements listed below, this guidance authorizes State-licensed pharmacists to order and administer, and State-licensed or registered pharmacy interns acting under the supervision of the qualified pharmacist to administer, to persons ages three or older COVID-19 vaccinations that have been authorized or licensed by the Food and Drug Administration (FDA)."
United States. Department of Health and Human Services
2020-09-03
-
Investigational COVID-19 Convalescent Plasma: Guidance for Industry [September 2, 2020]
From the Introduction: "FDA plays a critical role in protecting the United States (U.S.) from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic. On August 23, 2020, FDA issued an Emergency Use Authorization (EUA) for COVID-19 convalescent plasma for the treatment of hospitalized patients with COVID-19. FDA recognizes that while COVID-19 convalescent plasma may be used under an EUA consistent with the authorization, COVID-19 convalescent plasma may also be used under an investigational new drug application (IND). For the purposes of this guidance, the term 'COVID-19 convalescent plasma' refers to the convalescent plasma authorized under the EUA, while the term 'investigational convalescent plasma' refers to convalescent plasma that does not meet all the conditions of the EUA and/or is being used under an IND. FDA is issuing this guidance to provide recommendations to health care providers and investigators on the use of COVID-19 convalescent plasma or investigational convalescent plasma during the public health emergency. The guidance also provides recommendations to blood establishments on collection. We also describe FDA's interim compliance and enforcement policy regarding the IND requirements for the use of investigational convalescent plasma. This document supersedes the guidance of the same title issued in April 2020 and updated in May 2020."
United States. Food and Drug Administration; United States. Department of Health and Human Services; Center for Biologics Evaluation and Research (U.S.)
2020-09-02
-
Rural Action Plan
From the Executive Summary: "The Rural Action Plan provides a description of the current rural health care and human services landscape, particularly the challenges rural individuals and communities face in accessing and financing health care and human services. The characteristics of rural health and human service disparities include poorer health status, with residents of rural areas more likely than their urban counterparts to die from heart disease, cancer, unintentional injury, chronic lower respiratory disease, and stroke, and to have health care and human service workforce shortages, fragile provider networks, and the limited and varied capabilities of public health and human services departments, among others. In acknowledgment of these rural health disparities, the foundation of the Rural Action Plan is based on the following Four-Point Strategy: 1. 'Build a Sustainable Health and Human Services Model for Rural Communities' by empowering rural providers to transform service delivery on a broad scale. 2. 'Leverage Technology and Innovation' to deliver quality care and services to rural communities more efficiently and cost-effectively. 3. 'Focus on Preventing Disease and Mortality' by developing rural-specific efforts to improve health outcomes. 4. 'Increase Rural Access to Care' by eliminating regulatory burdens that limit the availability of needed clinical professionals."
United States. Department of Health and Human Services
2020-09
-
ASPR TRACIE Technical Assistance Request: CMS Emerging Infectious Disease Terminology Requirements in Hazard Vulnerability Assessments
From the Document: "The requestor contacted ASPR [Assistant Secretary for Preparedness and Response] TRACIE [Technical Resources, Assistance Center, and Information Exchange] and asked if their healthcare facility needed to change their current terminology from 'pandemic/ epidemic' to 'emerging infectious diseases' (EID) in their Hazard Vulnerability Assessment (HVA) per the Centers for Medicare & Medicaid Services (CMS) Emergency Preparedness (EP) Rule."
United States. Department of Health and Human Services. Office of the Assistant Secretary for Preparedness and Response; United States. Technical Resources, Assistance Center and Information Exchange
2020-08-17
-
Reopening Guidance Currently Available by State
This document provides hyperlinks to Reopening Guidance Currently Available by State as of August 11, 2020.
United States. Department of Health and Human Services
2020-08-11
-
Updated Guidance on HIPAA and Contacting Former COVID-19 Patients About Plasma Donation (August 2020)
From the Document: "The HIPAA [Health Insurance Portability and Accountability Act] Privacy Rule permits HIPAA-covered entities (or their business associates on the covered entities' behalf) to use or disclose PHI [protected health information] for treatment, payment, and health care operations, among other purposes, without an individual's authorization. Health care operations include case management and care coordination activities that do not meet the definition of treatment (e.g., where a health plan undertakes case management or care coordination, or where a health care provider undertakes such activities in a manner that is not connected to the care of a specific individual). When using or disclosing PHI for health care operations, the covered entity must make reasonable efforts to limit the use or disclosure of PHI to the minimum necessary to accomplish the intended purpose of the use or disclosure."
United States. Department of Health and Human Services. Office for Civil Rights
2020-08
-
Opioid Use in Medicare Part D Continued to Decline in 2019, but Vigilance is Needed as COVID-19 Raises New Concerns
From the Document: "The United States has been grappling with the opioid crisis for several years. In 2018, nearly 47,000 opioid-related overdose deaths occurred in the United States. The Office of Inspector General (OIG) has been tracking opioid use in Medicare Part D since 2016. In particular, OIG has identified beneficiaries at serious risk of opioid misuse or overdose and prescribers with questionable opioid prescribing for these beneficiaries. This data brief provides important information on opioid use in Medicare Part D in 2019, before the coronavirus disease 2019 (COVID-19) pandemic. This information is critical to understanding trends in opioid use. This data brief will also provide comparison points for a forthcoming OIG data brief, which will examine changes in opioid use that occurred during the pandemic in 2020."
United States. Department of Health and Human Services. Office of Inspector General
2020-08
-
ASPR TRACIE Technical Assistance Request: Handling and Viewing the Remains of a Deceased COVID-19 Patient [30 July 2020]
From the Document: "The requestor asked for precautions or guidance related to handling and viewing the remains of a deceased COVID-19 [coronavirus disease 2019] patient as well as planning resources for mass fatality management."
United States. Department of Health and Human Services. Office of the Assistant Secretary for Preparedness and Response; United States. Technical Resources, Assistance Center and Information Exchange
2020-07-30
-
Medicare Beneficiary Use of Telehealth Visits: Early Data from the Start of the COVID-19 Pandemic
From the Document: "During the early days of the Coronavirus disease 2019 (COVID-19) pandemic in the US from March through May 2020, Medicare primary care in-person visits plummeted, but as a result of the flexibilities introduced to address the pandemic, they were partially offset by a substantial increase in telehealth visits. Telehealth visits have continued, even after in-person primary care visits resumed, suggesting continued interest in telehealth for millions of Medicare beneficiaries."
United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation
Bosworth, Arielle; Ruhter, Joel; Samson, Lok Wong . . .
2020-07-28
-
Use of Telemedicine in Alternate Care Sites [presentation]
This presentation provides an overview of telemedicine as used at alternate care sites. The topics addressed include: "Virtual Care Tech"; "COVID-19 [coronavirus disease 2019] Response Areas"; "Uses/Impact"; "Practical Considerations"; "Field Operations"; implementation at "Javits New York Medical Station"; "Telemedicine Capability"; "Lessons Learned"; and "Best Practices."
United States. Technical Resources, Assistance Center and Information Exchange; United States. Department of Health and Human Services. Office of the Assistant Secretary for Preparedness and Response
2020-07-28
-
Bulletin: Civil Rights Protections Prohibiting Race, Color and National Origin Discrimination During COVID‐19: Application of Title VI of the Civil Rights Act of 1964
From the Document: "As part of the national response to the COVID‐19 [coronavirus disease 2019] public health emergency, the U.S. Department of Health and Human Services (HHS) has provided substantial Federal financial assistance to state and local agencies, hospitals, and other healthcare providers on the front lines of the COVID‐19 response. The Office for Civil Rights (OCR) continues to issue guidance to ensure that the recipients of this Federal financial assistance understand that they must comply with applicable Federal civil rights laws and regulations that prohibit discrimination on the basis of race, color, national origin, disability, age, sex, and exercise of conscience and religion in HHS‐funded programs. This Bulletin focuses on recipients' compliance with the prohibitions against race, color, and national origin discrimination contained in Title VI of the Civil Rights Act of 1964 (Title VI)."
United States. Department of Health and Human Services. Office for Civil Rights
2020-07-20
-
Coronavirus (COVID-19) Pandemic: Personal Protective Equipment Preservation Best Practices [July 13, 2020]
From the Document: "This fact sheet summarizes best practices for national implementation to sustain personal protective equipment (PPE) while ensuring the protection of healthcare personnel (HCP) and first responders during the coronavirus (COVID-19) pandemic response."
United States. Federal Emergency Management Agency; United States. Department of Health and Human Services
2020-07-13
-
COVID-19 Guidance for Hospital Reporting and FAQs for Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting, Updated July 10, 2020
From the Document: "On March 29, 2020, Vice President Pence sent a letter to hospital administrators across the country requesting daily data reports on testing, capacity and utilization, and patient flows to facilitate the public health response to the 2019 Novel Coronavirus (COVID-19). Many separate governmental entities are requesting similar information, resulting in stakeholder requests to reduce duplication and minimize reporting burden. This document details the Federal Government's data needs, explains the division of reporting responsibility between hospitals and states, and provides clear, flexible options for the timely delivery of this critical information. The objective is to allow states and hospitals either to leverage existing data reporting capabilities or, where those capabilities are insufficient, to provide guidance in how to build upon existing capabilities."
United States. Department of Health and Human Services
2020-07-10
-
ELC Enhancing Detection: Kentucky Testing Plan
From the Document: "Kentucky's estimated population is 4.5 million residents. To reach the monthly 2% minimum testing target, 90,000 tests/month (3,000 tests/day) will need to be performed within the commonwealth. Through the Gravity Diagnostics contract, Kentucky has the capacity to perform 125,000 tests/month or 5,000 tests/day (Monday-Saturday), exceeding the monthly minimum. The Division of Laboratory Services (DLS) has recently expanded its testing capacity to approximately 240 specimens/day (Monday-Sunday). In addition to the current capacity, DPH must continue to increase the availability and accessibility of testing. To stop transmission of COVID-19 [coronavirus disease 2019], the primary goals are to identify as close to 100% of infected persons as quickly as possible and isolate cases immediately, as well as identify and quarantine their close contacts and monitor for symptoms"
United States. Department of Health and Human Services
2020-07-09?
-
ELC Enhancing Detection: South Dakota Testing Plan
From the Document: "SDPHL [South Dakota Public Health Laboratory] performs the 2019-nCoV [2019 novel coronavirus] RT-PCR [reverse transcription polymerase chain reaction] test designed to detect the SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus from respiratory specimens such as nasopharyngeal (NP), oropharyngeal (OP), and sputum specimens. SDPHL performs nucleic acid extraction on three Roche LC2.0 extractors, three Qiagen EZ-1 Advanced, and one Kingfisher instruments. SDPHL performs real-time reverse transcriptase polymerase chain reaction (RTPCR) on three Thermo Fisher ABI 7500 Fast DX and two QuantStudio instruments. SDPHL will add one additional Kingfisher and one Thermo Fisher ABI 7500 Fast DX to the state COVID-19 testing infrastructure. The current RT-PCR infrastructure at SDPHL can perform over 300 specimens in a conventional workday. Proposed RT-PCR infrastructure expansion will increase that throughput to almost 500 specimens each day."
United States. Department of Health and Human Services
2020-07-08?
-
ELC Enhancing Detection: Nebraska Testing Plan
From the Document: "Nebraska Department of Health and Human Services (NDHHS) is utilizing multiple avenues in order to increase and maintain testing capacity to thoroughly provide access to Nebraskans in both the urban population centers and in the rural/frontier areas on a consistent basis. In order to accomplish, the goal of testing at least 2% of the state's population (estimated at 38,700 tests/month or 1,300 tests/day based on 2019 U.S. Census estimates) NDHHS is working with local public health department partners; medical and health care professional associations; public and private laboratories; health care facilities, systems, and providers; large employers such as distributors, manufacturers, and meat processing facilities; pharmacies; academic institutions; as well as many others. The main strategies NDHHS is utilizing include (1) identifying and maximizing testing platforms throughout the state; (2) identifying points-of-care to perform small and large scale testing; (3) identifying areas, industries, and populations that are at an increased risk for infection or severe outcomes; and (4) localized and statewide communication and outreach plans."
United States. Department of Health and Human Services
2020-07-08?
-
ELC Enhancing Detection: New Hampshire Testing Plan
From the Document: "The State of New Hampshire currently has two sites performing high throughput testing, the New Hampshire State Public Health Laboratories (PHL) and Dartmouth Hitchcock Medical Center (DHMC). PHL: Since early March 2020, the PHL has been veriying RNA [ribonucleic acid] extraction platforms, PCR [polymerase chain reaction] Kits and PCR instruments to increase its testing capacity. Currently, the PHL has one each of MagNA Pure 24, Qiagen EZ1 and King Fisher Flex instrument for RNA extraction and six ABI7500 instruments running CDC [Centers for Disease Control and Prevention] EUA [Emergency Use Authorization] assay with the capacity to test ~500 samples/day. The PHL is expecting to receive and verify a Hologic Pabther Fusion instrument in early August. The Panther Fusion will allow the PHL to perform an additional ~500 tests/day begining [sic] in August 2020."
United States. Department of Health and Human Services
2020-07-08?
-
ELC Enhancing Detection: Montana Testing Plan
From the Document: "The state of Montana has developed a COVID-19 [coronavirus disease 2019] Testing Plan designed to expand current testing capacity beyond symptomatic individuals. Identifying COVID infections as early as possible will allow for public health contact tracing and implementation of interventions to prevent and respond to outbreaks. The expansion of testing in asymptomatic, at-risk populations such as long-term care and clinical settings serving underserved populations, is a component of state and national strategies to better detect and understand transmission of the virus responsible for COVID-19. Sentinel testing may allow us to detect and respond to the transmission of the virus in high-risk settings at an earlier stage and improve containment efforts. In addition to providing useful information in key populations and helping guide response efforts, surveillance testing may help us assess our efforts to protect essential and frontline workers who interface with others in the community who may be at a higher risk for exposure."
United States. Department of Health and Human Services
2020-07-08?
